导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.25% | 702/1050 |
| 近一周 | 0.02% | 286/1104 |
| 近一月 | -4.58% | 728/1103 |
| 近一季 | 11.02% | 94/1092 |
| 近半年 | -0.86% | 478/1070 |
| 近一年 | -16.34% | 835/1018 |
| 近两年 | 26.50% | 719/926 |
| 近三年 | -2.37% | 699/834 |
| 成立以来 | 43.76% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.37% 674/1070 |
-2.98% 756/1101 |
- - |
- - |
| 2025 | 17.76% 705/1065 |
5.59% 370/1014 |
6.37% 221/1038 |
21.30% 569/1050 |
-13.56% 961/1065 |
| 2024 | -13.36% 829/1011 |
-8.61% 725/960 |
-4.95% 633/983 |
7.02% 816/991 |
-6.81% 770/1011 |
| 2023 | -10.49% 348/952 |
2.54% 474/880 |
-2.48% 336/895 |
-8.28% 518/915 |
-2.41% 262/952 |
| 2022 | -14.11% 153/867 |
-14.48% 231/773 |
3.49% 608/806 |
-9.56% 218/845 |
7.32% 130/867 |
| 2021 | -5.75% 427/740 |
-3.98% 305/580 |
23.92% 103/659 |
-12.20% 564/704 |
-9.78% 656/740 |
| 2020 | 66.97% 155/554 |
15.34% 20/419 |
38.31% 38/466 |
-4.53% 458/517 |
9.63% 369/554 |
| 2019 | - - |
- - |
- - |
13.95% 53/390 |
5.71% 324/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中金新医药股票C VS. 东吴新产业精选股票A(580008) |